Edwards Lifesciences (Edwards Lifesciences) COGS-to-Revenue : 0.23 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Edwards Lifesciences COGS-to-Revenue?

Edwards Lifesciences's Cost of Goods Sold for the three months ended in Dec. 2023 was $357 Mil. Its Revenue for the three months ended in Dec. 2023 was $1,534 Mil.

Edwards Lifesciences's COGS to Revenue for the three months ended in Dec. 2023 was 0.23.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Edwards Lifesciences's Gross Margin % for the three months ended in Dec. 2023 was 76.74%.

Edwards Lifesciences COGS-to-Revenue Historical Data

The historical data trend for Edwards Lifesciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences COGS-to-Revenue Chart

Edwards Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.26

0.25

0.24

0.20

0.23

Edwards Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.19	0.23	0.22	0.24	0.23

Edwards Lifesciences COGS-to-Revenue Calculation

Edwards Lifesciences's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1379.8	/	6004.8
	=	0.23

Edwards Lifesciences's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	356.9	/	1534.1
	=	0.23

Edwards Lifesciences (NYSE:EW) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Edwards Lifesciences's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	356.9 / 1534.1
	=	76.74 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Edwards Lifesciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (Edwards Lifesciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (NYSE:EW) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

EW:Mexico 1EW:Italy EWL:Germany EWL:Germany EWL:Germany E1WL34:Brazil EWLS:Austria

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Executives

Bobo Donald E Jr	officer: CVP,Strategy/Corp Development	C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614
Michael A Mussallem	director, officer: Chairman & CEO	C/O EDWARDS LIFESCIENCES CORP, ONE EDWARDS WAY, IRVINE CA 92614
Scott B. Ullem	officer: CVP, CFO	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Daveen Chopra	officer: CVP, Surgical Structural Heart	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92618
Larry L Wood	officer: CVP, THV Replacement	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Catherine M. Szyman	officer: CVP, Critical Care	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Wayne Markowitz	officer: GM & SVP, Surgical	ONE EDWARDS WAY, IRVINE CA 92614
Heisz Leslie Stone	director	C/O PUBLIC STORAGE, 701 WESTERN AVENUE, GLENDALE CA 91201
Jean-luc M Lemercier	officer: CVP, EMEA, Canada, Latin Amer	C/O ONE EDWARDS WAY, IRVINE CA 92614
Sellers Robert W.a.	officer: VP, Corp. Controller (Principa	ONE EDWARDS WAY, IRVINE CA 92614
Bernard J Zovighian	officer: CVP, Surgical Heart Valves	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Huimin Wang	officer: CVP, Japan & Intercontinental	C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614
Martha H. Marsh	director	9769 WEXFORD CIRCLE, GRANITE BAY CA 95746
Kieran Gallahue	director	PO BOX 684369, PARK CITY UT 84068
Nicholas J Valeriani	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614